Log in
Products
Latest News
FAQ
Log in
|
Search
Search
Filters
Clear All
Study Phase
Early Phase 1
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
Phase 4
Not Applicable
Recruitment Status
Recruiting
Not yet recruiting
Active, not recruiting
Completed
Suspended
Terminated
Withdrawn
Study Type
Interventional
Observational
Expanded Access
Others
Eligibility Sex
All
Female
Male
Healthy Volunteers
All
Include
Exclude
Found
1
clinical trials
|
View Analysis
Sort by:
Newest First
PRospective rEgistry OF Advanced Stage cancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine
Recruiting
Conditions
Uterine Cancer
Colorectal Cancer
Pancreatic Cancer
Melanoma
Prostate Cancer
Stomach Cancer
Esophageal Cancer
Rhabdomyosarcoma
Lung Cancer
Breast Cancer
Expand All (13)
Interventions
Diagnostic Test: OmniSeq Test
Subscribe
First Posted Date
2023-01-25
Last Posted Date
2023-04-27
Lead Sponsor
Labcorp Corporation of America Holdings, Inc
Target Recruit Count
2500
Registration Number
NCT05697198
Locations
🇺🇸
Clinical Site, Rock Hill, South Carolina, United States
Subscribe
Prev
1
Next
© Copyright 2025. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy